These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33407967)

  • 21. Midodrine for Recurrent Vasovagal Syncope: A Systematic Review and Meta-analysis of Randomized Control Trials.
    Mhanna M; Beran A; Mhanna AS; Al-Abdouh A; Jabri A; Numan MJ; Alsaiqali M; Musallam R; Zerihun K; Mahmood A
    Am J Ther; 2024 Jan-Feb 01; 31(1):e87-e91. PubMed ID: 35703495
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
    Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of midodrin treatment of vasovagal syncope].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2004; 76(8):38-41. PubMed ID: 15471395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2006; 78(4):64-8. PubMed ID: 16821426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope.
    Samniah N; Sakaguchi S; Lurie KG; Iskos D; Benditt DG
    Am J Cardiol; 2001 Jul; 88(1):A7, 80-3. PubMed ID: 11423066
    [No Abstract]   [Full Text] [Related]  

  • 26. A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.
    Mizuguchi Y; Ishimoto T; Kageyama N; Oishi Y; Emi S; Nagase N; Oki T
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):405-8. PubMed ID: 15717144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient treated with tilt training and midodrine after 68 seconds asystole during head-up tilt table testing.
    Oz F; Cizgici Y; Bilge AK
    Acta Cardiol; 2011 Aug; 66(4):523-5. PubMed ID: 21894812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
    Klingenheben T; Credner S; Hohnloser SH
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):276-81. PubMed ID: 10087541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic prevention of recurrent vasovagal syncope: A systematic review and network meta-analysis of randomized controlled trials.
    Behnoush AH; Yazdani K; Khalaji A; Tavolinejad H; Aminorroaya A; Jalali A; Tajdini M
    Heart Rhythm; 2023 Mar; 20(3):448-460. PubMed ID: 36509319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and therapy of vasovagal syncope: A review.
    Aydin MA; Salukhe TV; Wilke I; Willems S
    World J Cardiol; 2010 Oct; 2(10):308-15. PubMed ID: 21160608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful midodrin treatment for vasovagal syncopes accompanied by asystole].
    Pevzner AV; Kuchinskaia EA; Vershuta EV; Al'bitskaia KV; Kheĭmetz GI; Tripoten' MI; Rogoza AN; Golitsyn SP
    Klin Med (Mosk); 2004; 82(9):53-6. PubMed ID: 15540425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data.
    Liao Y; Li X; Zhang Y; Chen S; Tang C; Du J
    Acta Paediatr; 2009 Jul; 98(7):1194-200. PubMed ID: 19397534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
    Gracie J; Newton JL; Norton M; Baker C; Freeston M
    Europace; 2006 Aug; 8(8):636-43. PubMed ID: 16864617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
    Zhang Q; Jin H; Wang L; Chen J; Tang C; Du J
    Med Sci Monit; 2008 Apr; 14(4):CR199-203. PubMed ID: 18376348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent syncope in a 31-year-old army staff sergeant.
    Wiley TM; Luu VD
    Mil Med; 2002 Mar; 167(3):263-5. PubMed ID: 11901579
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of vasovagal syncope with convulsions--the effects of midodrine hydrochloride.
    Koyama S; Matsubara T; Aizawa Y; Ohshima M; Yamaguchi T; Yamazaki Y; Igarashi Y; Tamura Y; Yamazoe M; Izumi T
    Jpn Circ J; 1992 Sep; 56(9):950-4. PubMed ID: 1383579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.
    Grubb BP; Karas B; Kosinski D; Boehm K
    J Interv Card Electrophysiol; 1999 Jul; 3(2):139-43. PubMed ID: 10387140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing the Efficacy of Midodrine to Prevent Vasovagal Syncope.
    Brignole M
    Ann Intern Med; 2021 Oct; 174(10):1460-1461. PubMed ID: 34339220
    [No Abstract]   [Full Text] [Related]  

  • 40. Current approach to the treatment of vasovagal syncope in adults.
    Hatoum T; Raj S; Sheldon RS
    Intern Emerg Med; 2023 Jan; 18(1):23-30. PubMed ID: 36117230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.